Ramon E. R.
- Country
- Spain
- Department
- Lipidology
Research Overview
Data & Insights
Has run more than one trial at 0 of 67 partner sites.
Specializations
Lipidology and Atherosclerotic Cardiovascular Disease
Ramon Estruch Riba’s clinical research includes lipidology with a strong focus on cardiovascular risk, atherosclerotic cardiovascular disease, coronary artery disease, acute coronary syndrome, and myocardial infarction. His work also extends to atrial fibrillation, heart failure, hypertension, and hypertriglyceridemia, reflecting interest in cardiometabolic disease management.
- Atherosclerotic cardiovascular disease
- Acute coronary syndrome
- Heart failure
- Hypertriglyceridemia
His trial activity also includes prevention-oriented cardiovascular research linked to metabolic health and long-term vascular outcomes.
Hepatology and Liver Disease
Another major area of interest is hepatology, including chronic liver disease, cirrhosis, acute-on-chronic liver failure, decompensated cirrhosis, primary biliary cholangitis, primary sclerosing cholangitis, and metabolic dysfunction-associated steatotic liver disease. The research landscape also covers alcohol-related liver disease, hepatitis B, and hepatocellular carcinoma.
- Chronic liver disease
- Acute-on-chronic liver failure
- Primary biliary cholangitis
- Hepatocellular carcinoma
His involvement spans both inflammatory liver disorders and advanced liver-related complications requiring targeted therapeutic development.
Oncology with emphasis on Breast Cancer and Solid Tumors
Ramon Estruch Riba is active in a broad oncology portfolio centered on breast cancer, including hormone receptor-positive, HER2-negative, HER2-positive, triple-negative breast cancer, and metastatic breast cancer. His research also includes non-small cell lung cancer, small cell lung cancer, urothelial carcinoma, prostate cancer, ovarian cancer, and gastrointestinal cancers.
- Breast cancer
- Non-small cell lung cancer
- Urothelial carcinoma
- Prostate cancer
His trial landscape includes interest in molecularly defined tumors, metastatic disease, and treatment-resistant malignancies across multiple organ systems.
Hematologic Malignancies and Plasma Cell Disorders
His clinical trial profile includes extensive work in hematologic malignancies such as multiple myeloma, acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma. Related interests include myelodysplastic syndromes, myelofibrosis, and light chain amyloidosis.
- Multiple myeloma
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Light chain amyloidosis
This area reflects sustained engagement with blood cancers and related disorders that require specialized therapeutic strategies.
Immune-Mediated, Renal, and Neurologic Disorders
His research also covers immune-mediated diseases such as rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, Crohn’s disease, and ulcerative colitis, alongside renal diseases including chronic kidney disease, IgA nephropathy, and kidney transplant rejection. In neurology, his interests include Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, migraine, and progressive supranuclear palsy.
- Autoimmune disease
- Chronic kidney disease
- Alzheimer’s disease
- Parkinson’s disease
His portfolio spans chronic inflammatory, renal, and neurodegenerative conditions with substantial therapeutic relevance.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.